Attached files

file filename
EX-99.1 - EX-99.1 - Senseonics Holdings, Inc.sens_ex991current.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549


FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): November 10, 2016

SENSEONICS HOLDINGS, INC.

(Exact Name of Registrant as Specified in its Charter)

 

Delaware

 

001-37717

 

47-1210911

(State or Other
Jurisdiction of Incorporation)

 

(Commission File Number)

 

(IRS Employer
Identification No.)

 

20451 Seneca Meadows Parkway
Germantown, MD  20876-7005

(Address of Principal Executive Office) (Zip Code)

Registrant's telephone number, including area code:  (301) 515-7260

Not Applicable

Former name or former address, if changed since last report

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):

☐    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 


 

Item 8.01 Other Events

On November 10, 2016, Dr. Mark Christiansen, lead clinician in Senseonics Holdings, Inc.’s PRECISE II trial, presented a summary of the data from the PRECISE II trial at the Diabetes Technology Meeting in Bethesda, Maryland.  A copy of Dr. Christiansen’s presentation is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

 

 

Item 9.01 Exhibits.  

 (d) Exhibits.

ExhibitExhibit
NumberDescription

99.1    Presentation slides presented on November 10, 2016.

 


 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date:  November 10, 2016

SENSEONICS HOLDINGS, INC.

 

 

 

 

 

 

 

 

 

 

By:

/s/ R. Don Elsey

 

Name:

R. Don Elsey

 

Title:

Chief Financial Officer

 

 


 

 

 

EXHIBIT INDEX

 

 

 

 

Exhibit

 

 

Number

 

Exhibit Description

99.1

 

Presentation slides presented on November 10, 2016.